Cargando…

Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology

Spinal muscular atrophy (SMA) is characterized by motor neuron loss, caused by mutations or deletions in the ubiquitously expressed survival motor neuron 1 (SMN1) gene. We recently identified a novel role for Smn protein in glucose metabolism and pancreatic development in both an intermediate SMA mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bowerman, Melissa, Michalski, John-Paul, Beauvais, Ariane, Murray, Lyndsay M., DeRepentigny, Yves, Kothary, Rashmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049303/ https://www.ncbi.nlm.nih.gov/pubmed/24497575 http://dx.doi.org/10.1093/hmg/ddu052

Ejemplares similares

The Smn-Independent Beneficial Effects of Trichostatin A on an Intermediate Mouse Model of Spinal Muscular Atrophy
por: Liu, Hong, et al.
Publicado: (2014)

Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn(2b/-) mouse model of spinal muscular atrophy
por: Murray, Lyndsay M., et al.
Publicado: (2015)

Suppression of the necroptotic cell death pathways improves survival in Smn(2B/−) mice
por: Chehade, Lucia, et al.
Publicado: (2022)

Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2020)

Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy
por: Boyer, Justin G, et al.
Publicado: (2013)

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
por: Boyer, Justin G., et al.
Publicado: (2014)

The Proteolipid Protein Promoter Drives Expression outside of the Oligodendrocyte Lineage during Embryonic and Early Postnatal Development
por: Michalski, John-Paul, et al.
Publicado: (2011)

Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
por: Bowerman, Melissa, et al.
Publicado: (2012)

Effect of genetic background on the phenotype of the Smn(2B/-) mouse model of spinal muscular atrophy
por: Eshraghi, Mehdi, et al.
Publicado: (2016)

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017)

Low fat diets increase survival of a mouse model of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019)

Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2016)

Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy
por: Hunter, Gillian, et al.
Publicado: (2016)

Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice
por: Deguise, Marc-Olivier, et al.
Publicado: (2017)

Motor defects in a Drosophila model for spinal muscular atrophy result from SMN depletion during early neurogenesis
por: Grice, Stuart J., et al.
Publicado: (2022)

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy
por: Comley, Laura H, et al.
Publicado: (2022)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
por: Šoltić, Darija, et al.
Publicado: (2020)

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019)

Mouse Survival Motor Neuron Alleles That Mimic SMN2 Splicing and Are Inducible Rescue Embryonic Lethality Early in Development but Not Late
por: Hammond, Suzan M., et al.
Publicado: (2010)

SMN post-translational modifications in spinal muscular atrophy
por: Riboldi, Giulietta M., et al.
Publicado: (2023)

Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy
por: Groen, Ewout J N, et al.
Publicado: (2018)

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
por: Murray, Lyndsay, et al.
Publicado: (2014)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
por: Winkelsas, Audrey M., et al.
Publicado: (2021)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Publicado: (2020)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
por: Tsai, Li-Kai
Publicado: (2012)

AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn(2B/−) spinal muscular atrophy mice
por: Brown, Sharon J, et al.
Publicado: (2023)

Lysine-Less Variants of Spinal Muscular Atrophy SMN and SMNΔ7 Proteins Are Degraded by the Proteasome Pathway
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2017)

SMN1 dosage analysis in spinal muscular atrophy from India
por: Kesari, Akanchha, et al.
Publicado: (2005)

Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling
por: Sen, Anindya, et al.
Publicado: (2011)

Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy.
por: Shin, S., et al.
Publicado: (2000)

The Spinal Muscular Atrophy Disease Protein SMN Is Linked to the Golgi Network
por: Ting, Chen-Hung, et al.
Publicado: (2012)

25 years of the SMN genes: the Copernican revolution of spinal muscular atrophy
por: Tiziano, Francesco Danilo, et al.
Publicado: (2020)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
por: Valsecchi, Valeria, et al.
Publicado: (2023)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
por: Rademacher, Sebastian, et al.
Publicado: (2020)

Base editing as a genetic treatment for spinal muscular atrophy
por: Alves, Christiano R. R., et al.
Publicado: (2023)

Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies
por: Peeters, Kristien, et al.
Publicado: (2014)

Deletion analysis of SMN and NAIP genes in Tunisian patients with spinal muscular atrophy
por: Rekik, Imen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5onkthnjchja001ch83p6kbmed